Atlas Trials

Safety and Immunogenicity Study of Group B Meningococcal Vaccine to Prevent Meningitis.

Clinical trial NCT00248833 · COMPLETED

Trial details

NCT number
NCT00248833
Sponsor
U.S. Army Medical Research and Development Command
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Meningitis, Meningococcal, Serogroup B
Start date
2005-12-05
Primary completion
2006-11-30
Enrollment
34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.